| Name | Walgreen # 18949 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 7 E Silver St, Westfield, Massachusetts 01085 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (413) 568-5116 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A recently published cellular study on colorectal cancer showed that high-absorption BCM-95 Curcumin is able to reduce the spread of cancer cells and potentially increase the effectiveness of chemotherapy in the treatment of advanced colon cancer.
A suspected case of sexual transmission of Ebola virus disease (EVD) in Liberia was confirmed using genomic analysis, thanks to in-country laboratory capabilities established by U.S. Army scientists in collaboration with the Liberian Institute for Biomedical Research (LIBR).
Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
› Verified 6 days ago
| NPI Number | 1609391663 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #18949 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 7 E Silver St, Westfield, MA 01085 |
| Phone Number | 413-568-5116 |
News Archive
A recently published cellular study on colorectal cancer showed that high-absorption BCM-95 Curcumin is able to reduce the spread of cancer cells and potentially increase the effectiveness of chemotherapy in the treatment of advanced colon cancer.
A suspected case of sexual transmission of Ebola virus disease (EVD) in Liberia was confirmed using genomic analysis, thanks to in-country laboratory capabilities established by U.S. Army scientists in collaboration with the Liberian Institute for Biomedical Research (LIBR).
Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
› Verified 6 days ago
News Archive
A recently published cellular study on colorectal cancer showed that high-absorption BCM-95 Curcumin is able to reduce the spread of cancer cells and potentially increase the effectiveness of chemotherapy in the treatment of advanced colon cancer.
A suspected case of sexual transmission of Ebola virus disease (EVD) in Liberia was confirmed using genomic analysis, thanks to in-country laboratory capabilities established by U.S. Army scientists in collaboration with the Liberian Institute for Biomedical Research (LIBR).
Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
› Verified 6 days ago
Cvs Pharmacy #00838 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 427 East Main Street, Westfield, Massachusetts 01085 Phone: (413) 562-5181 | |
Cvs Pharmacy #01234 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 208 Elm St, Westfield, Massachusetts 01085 Phone: (413) 568-4149 | |
Stop And Shop Pharmacy #072 Type: Pharmacy Location: 57 Main St, Westfield, Massachusetts 01085 Phone: (413) 568-9660 | |
Wal-mart Pharmacy 10-2174 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 141 Springfield Rd, Westfield, Massachusetts 01085 Phone: (413) 572-0800 | |
Walgreen # 18949 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7 E Silver St, Westfield, Massachusetts 01085 Phone: (413) 568-5116 |